These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 3459357)

  • 21. The clinical relevance of the tumor marker CA 19-9 in the diagnosing and monitoring of pancreatic carcinoma.
    Safi F; Roscher R; Beger HG
    Bull Cancer; 1990; 77(1):83-91. PubMed ID: 2180502
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Comparative study of the role of CA 19-9, CA 72-4 and CEA tumor antigens in the diagnosis of pancreatic cancer and other gastrointestinal malignant diseases].
    Czakó L; Takács T; Babarczy E; Dux L; Lonovics J
    Orv Hetil; 1997 Nov; 138(47):2981-5. PubMed ID: 9432648
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Carcinoembryonic antigen in benign and malignant diseases of the digestive tract.
    Zamcheck N; Moore TL; Dhar P; Kupchik HZ; Sorokin JJ
    Natl Cancer Inst Monogr; 1972 Dec; 35():433-9. PubMed ID: 4659055
    [No Abstract]   [Full Text] [Related]  

  • 24. [Serum carcinoembryonic antigen (CEA) and carbohydrate antigen (CA 19-9) values in patients with pancreatic cancer or pancreatitis].
    Changchine CS; Yung CY; Tzen KY
    Changgeng Yi Xue Za Zhi; 1991 Mar; 14(1):32-8. PubMed ID: 2039968
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Serum determination of CA 19-9 in patients with digestive cancers and its diagnostic evaluation].
    Arakawa Y; Kobayashi H; Ozaki T; Ariga H; Matsuo Y; Honda T; Arai T; Kurosu Y; Morita K; Konuma H
    Gan To Kagaku Ryoho; 1984 Apr; 11(4):917-25. PubMed ID: 6586110
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Clinical significance of the circulating tumor-associated antigen CA 19-9 in cancers of the digestive tract].
    Staab HJ; Hornung A; Anderer FA; Kieninger G
    Dtsch Med Wochenschr; 1984 Jul; 109(30):1141-7. PubMed ID: 6204834
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CA 19-9 and pancreatic adenocarcinoma.
    Safi F; Beger HG; Bittner R; Büchler M; Krautzberger W
    Cancer; 1986 Feb; 57(4):779-83. PubMed ID: 3455839
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Monoclonal antibody detection of a circulating tumor-associated antigen. I. Presence of antigen in sera of patients with colorectal, gastric, and pancreatic carcinoma.
    Herlyn M; Sears HF; Steplewski Z; Koprowski H
    J Clin Immunol; 1982 Apr; 2(2):135-40. PubMed ID: 7068815
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The existence of alpha 1-fetoprotein apart from hepatoma].
    Andrieu J; Breart G; Rodier B; Robert PE
    Presse Med (1893); 1971; 79(36):1595-6. PubMed ID: 4328551
    [No Abstract]   [Full Text] [Related]  

  • 30. Clinical values of CA19-9, CA125 and CEA in malignant obstructive jaundice.
    Ng WW; Tong KJ; Tam TN; Lee SD
    Zhonghua Yi Xue Za Zhi (Taipei); 1995 Jun; 55(6):438-46. PubMed ID: 7634181
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Radioimmunoassay of carcinoembryonic antigen. A diagnostic test for carcinoma of the colon and pancreas.
    Nugent FW; Hansen ER
    Arch Intern Med; 1974 Jul; 134(1):59-61. PubMed ID: 4833933
    [No Abstract]   [Full Text] [Related]  

  • 32. Serum sialyl-Tn antigen levels in patients with digestive cancers.
    Motoo Y; Kawakami H; Watanabe H; Satomura Y; Ohta H; Okai T; Makino H; Toya D; Sawabu N
    Oncology; 1991; 48(4):321-6. PubMed ID: 1891175
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of carbohydrate antigens 19-9 and 12-5 in patients with pancreatic cancer.
    Pasquali C; Sperti C; D'Andrea AA; Bonadimani B; Del Favero G; Petrin P; Pedrazzoli S
    Pancreas; 1987; 2(1):34-7. PubMed ID: 3472197
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum CA242, CA199, CA125, CEA, and TSGF are Biomarkers for the Efficacy and Prognosis of Cryoablation in Pancreatic Cancer Patients.
    Chen Y; Gao SG; Chen JM; Wang GP; Wang ZF; Zhou B; Jin CH; Yang YT; Feng XS
    Cell Biochem Biophys; 2015 Apr; 71(3):1287-91. PubMed ID: 25486903
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Monoclonal antibodies against tumor-associated antigens of the gastrointestinal tract. Experimental and clinical outlook].
    Schmiegel WH; Kalthoff H
    Dtsch Med Wochenschr; 1985 Dec; 110(50):1943-9. PubMed ID: 3908048
    [No Abstract]   [Full Text] [Related]  

  • 36. Immunologic diagnosis of human digestive tract cancer. Carcinoembryonic antigens.
    Kamholz SL
    Am J Gastroenterol; 1973 Mar; 59(3):233-43. PubMed ID: 4121819
    [No Abstract]   [Full Text] [Related]  

  • 37. Tumor markers carbohydrate antigens CA 19-9 and CA-50 and carcinoembryonic antigen in pancreatic cancer and benign diseases of the pancreatobiliary tract.
    Harmenberg U; Wahren B; Wiechel KL
    Cancer Res; 1988 Apr; 48(7):1985-8. PubMed ID: 3349472
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Carcinoembryonic antigen in serum in diseases of the liver and pancreas.
    Khoo SK; Mackay IR
    J Clin Pathol; 1973 Jul; 26(7):470-5. PubMed ID: 4727056
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Detection of tumor associated antigen, PA8-15, in sera from pancreatic and gastrointestinal carcinoma patients.
    Arai M; Sakamoto K; Otsuka H; Yokoyama Y; Akagi M
    Jpn J Clin Oncol; 1990 Jun; 20(2):145-53. PubMed ID: 2370693
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of a new tumour marker CA 242 with CA 19-9, CA 50 and carcinoembryonic antigen (CEA) in digestive tract diseases.
    Kuusela P; Haglund C; Roberts PJ
    Br J Cancer; 1991 Apr; 63(4):636-40. PubMed ID: 2021550
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.